Archean Chemical Navigates Operational Headwinds, Charts Ambitious Future in Advanced Materials

Archean Chemical Industries Limited, a key player in specialty marine chemicals, recently shared its performance for Q3 and the nine months ended December 31, 2025. The company reported a consolidated revenue growth of 10.6% for the nine-month period, reaching INR 801.67 crore. For Q3 FY26, consolidated revenue grew by approximately 10% year-on-year. While the industrial salt segment demonstrated robust growth, the bromine business faced operational challenges, impacting overall profitability.

For the nine-month period, consolidated EBITDA stood at INR 216.6 crore, with a net profit of INR 93.18 crore. The industrial salt segment was a standout performer, with revenue growing 29% to INR 532.98 crore and volumes increasing 39% to 3.07 million tons for 9MFY26, driven by healthy demand. In contrast, bromine revenues declined by 22% to INR 214.65 crore, and volumes fell by 32% to 9,531 tons, primarily due to technical reasons affecting production. Management has initiated corrective measures to improve plant efficiencies in this segment. The company's strong export focus continues, with nearly 79% of its total operating revenues coming from international markets.

Strategic Diversification and Advanced Materials Push

Archean Chemical is not just focused on its core marine chemicals business; it is actively diversifying into advanced materials, particularly semiconductors and energy storage, aligning with India's strategic priorities. The company's investment in Clas-Sic Wafer Fab Limited in the UK, where it holds a 21% stake, secures exclusive access to advanced Silicon Carbide (SiC) technology for India. This investment underpins the broader semiconductor strategy through its step-down subsidiary, SiCSem Private Limited.

SiCSem Private Limited is poised to establish India's first commercial SiC-based Compound Semiconductor fab in Info Valley, Bhubaneshwar, Odisha. The project, approved by the India Semiconductor Mission (ISM) in August 2025, will integrate the entire manufacturing process for power devices. With a planned annual capacity of 60,000 wafers and packaging capacity of 96 million units, this facility aims to cater to critical sectors such as Defence, Electric Vehicles (EVs), Railway, Fast Chargers, Data Centre racks, Consumer Appliances, and Solar Power Inverters. The groundbreaking ceremony for this ambitious project took place in November 2025, marking a significant step towards execution.

Venturing into Energy Storage

Further demonstrating its strategic foresight, Archean Chemical has invested in Offgrid Energy Labs, securing an 18.14% stake in May 2025. This move is expected to be completed in FY26 and aligns with the company's broader strategy to enter the energy storage sector, focusing on renewable energy applications, industrial storage, and grid stability. Offgrid Energy Labs specializes in patented Zinc Bromide battery technology, which offers superior cycle life, safety, and cost-effectiveness compared to traditional lithium-ion batteries.

Archean is actively supporting the establishment of a pilot manufacturing facility for these batteries in the UK, with plans for a giga-factory in India in the near future. This initiative leverages Archean's bromine business, which has a direct synergy with zinc-bromide chemistry, creating a long-term value proposition in the rapidly growing energy storage market.

Operational Improvements and Future Outlook

While the company acknowledges operational challenges, particularly in bromine production due to technical reasons and weather impacts, management is committed to course correction. Several improvement projects have been launched to restore plant efficiencies, with expectations to return to steady-state operations in Q4 FY26. The company aims to achieve a bromine production run rate of 18,000 to 25,000 tons in the next year, with further expansion planned beyond this level.

In the Sulphate of Potash (SOP) segment, pilot stage trials have been successfully completed, and the company is progressing towards plant-scale trials. Meaningful contributions from SOP are anticipated in the latter half of FY27, following necessary plant modifications to adapt to brine quality changes. The bromine derivatives business is also seeing accelerated product development, with 15 new products in the pipeline, targeting 50-60% utilization in the coming quarters.

Archean Chemical Industries Limited is clearly navigating a period of both operational adjustments and strategic transformation. Despite some near-term headwinds and project delays, the management's focus on strengthening fundamentals, driving focused growth, and making significant investments in future-oriented sectors like semiconductors and energy storage positions the company for sustained long-term value creation. The emphasis on product development, market diversification, and operational excellence underscores a confident outlook for Archean Chemical's journey ahead.